Fuji Pharma Co., Ltd. (TYO:4554)
Japan flag Japan · Delayed Price · Currency is JPY
1,361.00
+4.00 (0.29%)
May 2, 2025, 3:30 PM JST

Revenue by Product

Fiscal year is October - September.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
Product - Hormones
18.02B
Log In
Log In
Log In
Log In
Product - Hormones Growth
12.29%
Log In
Log In
Log In
Log In
Product - Others
11.74B
Log In
Log In
Log In
Log In
Product - Others Growth
19.20%
Log In
Log In
Log In
Log In
Product - Diagnostic Drugs
8.06B
Log In
Log In
Log In
Log In
Product - Diagnostic Drugs Growth
5.06%
Log In
Log In
Log In
Log In
Product - Metabolic Drugs
2.08B
Log In
Log In
Log In
Log In
Product - Metabolic Drugs Growth
0.92%
Log In
Log In
Log In
Log In
Product - Tissue Cell Function Drug
1.28B
Log In
Log In
Log In
Log In
Product - Tissue Cell Function Drug Growth
26.73%
Log In
Log In
Log In
Log In
Merchandise - Hormones
1.21B
Log In
Log In
Log In
Log In
Merchandise - Hormones Growth
30.59%
Log In
Log In
Log In
Log In
Product - Nervous System and Sensory Organ Agents
716.00M
Log In
Log In
Log In
Log In
Product - Nervous System and Sensory Organ Agents Growth
-4.41%
Log In
Log In
Log In
Log In
Product - Antibiotics and Chemotherapeutic Agents
533.00M
Log In
Log In
Log In
Log In
Product - Antibiotics and Chemotherapeutic Agents Growth
-15.40%
Log In
Log In
Log In
Log In
Product - Cardiovascular Drugs
469.00M
Log In
Log In
Log In
Log In
Product - Cardiovascular Drugs Growth
-
Log In
Log In
Log In
Log In
Other
219.00M
Log In
Log In
Log In
Log In
Other Growth
-59.37%
Log In
Log In
Log In
Log In
Merchandise - Others
-
Log In
Log In
Log In
Log In
Merchandise - Others Growth
-
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is October - September.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
Japan
46.14B
Log In
Log In
Log In
Log In
Japan Growth
12.84%
Log In
Log In
Log In
Log In